Pain Management News

SAN DIEGO — Thoroughly documenting all patient interactions may help address physicians’ trepidation regarding opioid prescriptions, according to a speaker at the Congress of Clinical Rheumatology West.

This episode delves into what we can learn about the impact of the environment on autoimmunity, digging into how rates of autoimmunity can vary drastically in different parts of the world.

Lower back pain remains the leading global cause of years lived with disability, while projections estimate that more than 800 million people will experience lower back pain by 2050, according to data published in The Lancet Rheumatology.

On this special episode of Rheuminations, I interview comedian and ophthalmologist William Flanary, MD, and Kristin Flanary, also known as the Glaucomfleckens, on hypermobility and physician burnout.

Popular myths continue to influence the way physicians and patients alike think about and engage with chronic pain and the use of opioids, according to a speaker at the 2023 Biologic Therapies Summit.

DESTIN, Fla. — Significantly more research into the risks and benefits of cannabinoids is necessary to keep pace with both medicinal and recreational use in the U.S., noted a presenter at the 2023 Congress of Clinical Rheumatology-East.

Mehret Birru Talabi, MD, PhD, associate program director of the rheumatology fellowship training program at the University of Pittsburgh Medical Center, spoke with Healio about challenges patients with rheumatology face with fertility, how their RA symptoms are affected during pregnancy, and what they can to help improve their symptoms after giving birth.

In this issue of Healio Rheumatology, we have touched upon a topic that is incredibly important not only for our field of rheumatology, but for health care in general — namely, the issue of chronic pain and all its dimensions.

This month, our featured roundtable assembled an esteemed panel of experts on pain to help unravel the complexities we face with our patients who have chronic unresponsive pain, often in the setting of systemic immune-mediated disorders.

For more than a decade, the medical community as a whole, and particularly the field of rheumatology, has been trying to move away from opioids for the management of chronic pain — with varying degrees of success.